Problem: Procuring an organ for an organ transplant is nearly impossible. In fact, there are over 100,000 people on the waiting list in the US alone; 17 Americans die everyday waiting for transplant (HRSA, 2023). Even after having an organ there is a huge risk that the organ will be rejected by the patient’s body, as it may consider it foreign due to having different antigens than that of the patient’s body.
Subscribe here to get access to the first 500 ideas from our blog. For just one coffee a month, you can have access to more than $500 billion dollars of ideas. What's not to love?
Solution: In a world where medical sciences continually push the boundaries of what’s possible, a ground-breaking solution to one of the most challenging issues in healthcare has emerged - 3D printed organs. Imagine a future where procuring an organ for a lifesaving transplant is no longer a daunting, nearly impossible task. Picture a scenario where patients no longer have to worry about their bodies rejecting transplanted organs due to antigen mismatches. This is not science fiction; it is the future of organ transplantation, and it’s closer than you might think.
The concept of bio-printing has gained significant traction over recent years as the next big disruption in the health-tech industry. The key idea behind this revolutionary approach is to harness the power of 3D printing technology to create replacement organs using a patient’s own tissue samples. This idea has the potential to eliminate the agonisingly long waitlists for organ donors and the tragic cases of lost lives of awaiting individuals.
Another major problem this idea eliminates is the inherent immune response that can occur due to the identification of the transplant organ as foreign by the patient’s immune system by utilising a patient’s own tissue samples to create a personalised organ replica, the chances of organ rejections drop drastically. This is because the bio-printed possess the same antigenic characteristics as the patient’s body, making it virtually indistinguishable.
In essence, the research and development of 3D printed organs, coupled with the utilisation of patient specific tissue samples, has the potential to revolutionise organ transplantation. This approach addresses the long-standing problems of organ scarcity and rejection risks, offering a glimpse into the future where customised, perfectly matched organs can be created on demand. This idea has the potential to usher in a transformative era, with a global impact comparable to that of X-Rays and antibiotics.
Business Model: Right now, there are no 3D printers which possess the capability to create organs; current printers can only print skin cells. We can start a firm that specialises in research and development backed by venture capitalists. We then develop a concept and file patents for these ideas. From here on we have 3 options:
Sell the company to another firm.
Get additional backing from more venture capitalists to start developing a working prototype and then manufacture and sell the units to hospitals and specialist health centres.
Develop a working prototype with additional backing from venture capitalists and start a specialist health firm which provides the bio-printing services to hospitals.
Monetisation: For option 1 it is from the sale of the company. For option 2 it is from the sale of the bio-printers. For option 3 it is revenue generated from contractual agreements with hospitals to provide 3D printing services. It is important to note that monetizing this idea is contingent upon having successful research and development of 3D printed organs.
Contributed by: Parthiv Chowdary Anne (Billion Dollar Startup Ideas Intern); Idea by Ujjwal Chowdary Anne